Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

The initiation of the phase 2 study is based on early-stage data, which show that patients who received VKTX's obesity pill ...

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

In 2025, prioritizing health and managing weight remain essential goals for many. With numerous diets available, selecting ...

Losing weight can be tricky — which is why so many people struggle to find a solution that's right for them. And the amount ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

Here, MailOnline has analysed five of the most popular weight loss plans available to Brits to assess which is the most cost effective way to actually lose weight. Weight loss jabs How it ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

Weight loss is a popular topic of conversation, particularly at the start a new year when health and fitness resolutions are ...

Topline data were announced from the AUDACITY trial evaluating the Allurion Gastric Balloon, a swallowable, procedureless intragastric balloon, in adults with obesity.

and efficacy considerations,' the plans are also unrealistic. The weight loss jab Wegovy is already available on the NHS to some patients and around 220,000 with the greatest clinical need could ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...